Kinapse
Advisory, capability building and operational services to the life sciences industries.
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 32.3m | 39.4m | 43.4m | 25.6m | 17.7m | 13.7m | - |
| % growth | 29 % | 22 % | 10 % | (41 %) | (31 %) | (23 %) | - |
| EBITDA | 6.2m | 3.8m | (3.2m) | (2.0m) | (<1m) | 1.2m | (<1m) |
| % EBITDA margin | 19 % | 10 % | (7 %) | (8 %) | (1 %) | 9 % | - |
| Profit | 6.0m | 2.1m | 1.4m | (2.7m) | (<1m) | <1m | (<1m) |
| % profit margin | 18 % | 5 % | 3 % | (10 %) | (2 %) | 6 % | - |
| R&D budget | - | - | 6.0m | 3.0m | - | - | - |
| R&D % of revenue | - | - | 14 % | 12 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Growth Equity VC | ||
| N/A | N/A | Acquisition | |
N/A | Acquisition | ||
| Total Funding | - | ||
Recent News about Kinapse
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.